Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PICS: PTH and Ibandronate in Osteoporosis
NCT00683163Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- May 2008
- Primary completion
- Apr 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of parathyroid hormone 1-84 in osteoporosis (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Procollagen Type 1 N-Terminal Propeptide at 3 months. Started May 2008; status: completed.
02
Drugs
parathyroid hormone 1-84
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00683163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00683163.